We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Public Assessment Report of our review of the use of chloramphenicol eye drops containing borax and boric acid buffers in children under 2 years.
Guidance on the use of mydriatic eye drops in the NHS diabetic eye screening (DES) programme.
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
The eyesight rules to pass your driving test and for whenever you're driving.
These publications explain diabetic retinopathy and support the NHS diabetic eye screening (DES) programme.
Guidance for the NHS diabetic eye screening (DES) programme.
Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the medicinal product.
Executive summaries from local screening quality assurance (QA) visit reports of diabetic eye screening services, including recommendations.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).